These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 10969860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 3. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV, Rozenberg P, Bernard JP, Ville Y.
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract] [Full Text] [Related]

  • 4. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT.
    CMAJ; 1996 Feb 15; 154(4):465-79. PubMed ID: 8630836
    [Abstract] [Full Text] [Related]

  • 5. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL.
    Obstet Gynecol; 1992 Sep 15; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [Abstract] [Full Text] [Related]

  • 6. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K, Tanemura M, Murakami I, Okada S, Natori M, Tanaka M, Takagi T, Sato A.
    Prenat Diagn; 1997 Sep 15; 17(9):861-6. PubMed ID: 9316131
    [Abstract] [Full Text] [Related]

  • 7. Contemporary approaches to prenatal diagnosis.
    Kuller JA, Laifer SA.
    Am Fam Physician; 1995 Dec 15; 52(8):2277-83, 2285-6. PubMed ID: 7484721
    [Abstract] [Full Text] [Related]

  • 8. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO, Oz U, Shahabi S, Mahoney MJ, Baumgarten A, Cole LA.
    Am J Obstet Gynecol; 2000 Nov 15; 183(5):1114-8. PubMed ID: 11084551
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB, Nikolenko MI, Khlevnaia LA, Fedotova OO, Solov'eva VD, Malova SA.
    Tsitol Genet; 1998 Nov 15; 32(1):66-71. PubMed ID: 9695254
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study].
    Aymé S, Aurran Y, Chabal F, Gombert A, Loundou H, Montfort C, Sollier M, Silvestri A.
    Contracept Fertil Sex; 1993 Feb 15; 21(2):133-43. PubMed ID: 7524931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD, Greene N, Johnson A, Zachary J, Thom E, Krantz D, Simpson JL, Silver RK, Snijders RJ, Goetzl L, Pergament E, Filkins K, Mahoney MJ, Hogge WA, Wilson RD, Mohide P, Hershey D, MacGregor S, Bahado-Singh R, Jackson LG, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group.
    Obstet Gynecol; 2004 Oct 15; 104(4):661-6. PubMed ID: 15458882
    [Abstract] [Full Text] [Related]

  • 15. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR, Morris TC, Owen J, Stringer JS.
    Am J Obstet Gynecol; 2004 Mar 15; 190(3):721-9. PubMed ID: 15042005
    [Abstract] [Full Text] [Related]

  • 16. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A, Akkawi M.
    East Mediterr Health J; 2005 Jul 15; 11(4):824-7. PubMed ID: 16700399
    [Abstract] [Full Text] [Related]

  • 17. [Prenatal diagnosis of trisomy 21].
    Massé J, Forest JC.
    Ann Biol Clin (Paris); 1990 Jul 15; 48(8):536-40. PubMed ID: 1705107
    [Abstract] [Full Text] [Related]

  • 18. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Sep 15; 110(3):651-7. PubMed ID: 17766613
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    MacDonald ML, Wagner RM, Slotnick RN.
    Obstet Gynecol; 1991 Jan 15; 77(1):63-8. PubMed ID: 1701526
    [Abstract] [Full Text] [Related]

  • 20. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Heyl PS, Miller W, Canick JA.
    Obstet Gynecol; 1990 Dec 15; 76(6):1025-31. PubMed ID: 1700348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.